Attention Deficit Hyperactivity Disorder Drug ShortagesKimberly Sue N. Barrientos
Abstract: There is alarming concern in recent reports about the shortages of generic drugs used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Published: 10 January 2013 Cite as: Barrientos KSN. Attention Deficit Hyperactivity Disorder Drug Shortages. Bull Health L Policy. 2012;1(2).
Introduction In recent months, widespread shortage of generic ADHD drugs has caused difficulties for patients with ADHD. Those who require the medications are being forced to purchase expensive brand name drugs because generic versions are unavailable.1 The FDA, drug-manufacturing companies, and patients are blaming shortages on the Drug Enforcement Administration (DEA).2 Many manufacturers have reported that certain ADHD medications are in short supply, specifically generic versions of Adderall and Ritalin.3 The DEA has refused to acknowledge the shortage; they have placed blame for this shortage on the drug manufacturers’ decision to divide their manufacturing quota between generic and brand name drugs.4
No comments:
Post a Comment